| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 07/22/2004 | WO2004060362A2 COMPOSITIONS AND METHODS FOR INHIBITING TGF-β |
| 07/22/2004 | WO2004060261A2 Novel factor viia inhibiting compounds |
| 07/22/2004 | WO2004039313A3 Preventing desensitization of receptors |
| 07/22/2004 | WO2004002406A3 Bicyclic pyrimidinones as coagulation cascade inhibitors |
| 07/22/2004 | WO2003072135A3 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors |
| 07/22/2004 | WO2003059293A3 17-hydroxy-4-aza-androstan-3-ones as androgen receptor modulators |
| 07/22/2004 | WO2003044014A8 Indole-2-carboxamides as factor xa inhibitors |
| 07/22/2004 | WO2003017919A3 Composition comprising wenguanguo extracts, methods for preparing same and uses therof |
| 07/22/2004 | US20040142982 Urea derivatives as integrin alpha 4 antagonists |
| 07/22/2004 | US20040142976 Modulation cytokine sensitive diseases, cellular adhesion molecules; Aids therapy; antihistamines; antiarthritic agents; bone disorders; malaria; cachexia; Crohn's disease |
| 07/22/2004 | US20040142963 Cardiovascular disorders |
| 07/22/2004 | US20040142961 Utilization of substituted imidazo[1,2-a]-pyridine compounds in pharmaceutical formulations |
| 07/22/2004 | US20040142927 Inhibitors of p38 |
| 07/22/2004 | US20040142920 acute or chronic transplant rejection or inflammatory or autoimmune diseases |
| 07/22/2004 | US20040142919 Benzazepinone alpha vintegrin receptor antagonists |
| 07/22/2004 | US20040142877 Ligands of the $g(a)v$g(b)6 integrin |
| 07/22/2004 | US20040142867 Stabilized proteinic preparation |
| 07/22/2004 | US20040142431 Nucleotide sequences comprising restriction fragment length polymorphisms coding polypeptide with antiproliferative, antiviral and antiparasitic effects |
| 07/22/2004 | US20040141966 Inhibition of leukocyte adhesion |
| 07/22/2004 | US20040141912 Administering medicinally-useful agent which is phospholipid scramblase (PLS)-dependent transported compound to cells, thereby causing selective transport of agent into cells |
| 07/22/2004 | CA2514477A1 Novel factor viia inhibiting compounds |
| 07/21/2004 | EP1439176A1 Pyrimidone compounds and pharmaceutical compositions containing the same |
| 07/21/2004 | EP1438967A2 Pharmaceutical compositions of fibrinolytic agent |
| 07/21/2004 | EP1438415A2 Method for preparing heparin from mast cell cultures |
| 07/21/2004 | EP1438390A2 Circadian control of stem/progenitor cell self-renewal and differentiation and of clock controlled gene expression |
| 07/21/2004 | EP1438330A2 Peptide decoys for the preparation of medicaments that are intended for the prevention or treatment of autoimmune pathologies or problems linked to the appearance of antibodies directed against exogenous proteins |
| 07/21/2004 | EP1438313A1 Bicyclic oxopyridine and oxopyrimidine derivatives |
| 07/21/2004 | EP1438295A2 Azole derivatives and pharmaceutical compositions containing them |
| 07/21/2004 | EP1438293A2 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
| 07/21/2004 | EP1438292A1 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 07/21/2004 | EP1438104A1 Co-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists |
| 07/21/2004 | EP1438088A2 Bag system for cryopreservation of body fluids |
| 07/21/2004 | EP1438070A1 Treating vascular disease by inhibiting toll-like receptor-4 |
| 07/21/2004 | EP1438065A2 An in vivo animal model of chronic arterial occlusion and use of collagenase to facilitate guide wire crossing in chronic arterial occlusions |
| 07/21/2004 | EP1438061A2 Copolymers for suppression of autoimmune diseases, and methods of use |
| 07/21/2004 | EP1438052A1 INHIBITORS OF HUMAN PHOSPHATIDYL−INOSITOL 3−KINASE DELTA |
| 07/21/2004 | EP1438046A2 Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation, and methods for their use |
| 07/21/2004 | EP1320521B1 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives of cyclopentyl-heptan(en)oic acid as therapeutic agents |
| 07/21/2004 | EP1226137B1 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity |
| 07/21/2004 | EP1144369B1 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |
| 07/21/2004 | EP0958282B1 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines |
| 07/21/2004 | CN1514733A Modified erythropoietin (EPO) with reduced immunogenicity |
| 07/21/2004 | CN1513999A New earthworm kinase gene mutant |
| 07/21/2004 | CN1513500A Liu-Wei-Bu-Xue granule for invigorating blood contg. six herbal medicines and its prepn. method |
| 07/21/2004 | CN1513453A Controlled release tablet contg. pentoxifylline |
| 07/21/2004 | CN1158297C Steroid compounds with C17-alkyl side chain and aromatic A-ring for use in therapy |
| 07/21/2004 | CN1158279C 1-(P-thienylbenzyl)-imidazoles as angiotensin-(1-7) receptor agonists, method for production and utilization thereof and pharmaceutical preparations containing said compounds |
| 07/21/2004 | CN1158276C Phenyl-and pyridyl-tetrahydro-pyridines having TNF inhibiting activity |
| 07/21/2004 | CN1158107C Pharmaceutical compositions contg. platelet aggregation inhibitors |
| 07/21/2004 | CN1158085C Fe-Ca nutrient composition and its preparation method |
| 07/21/2004 | CN1158076C Thrombolytic injection for curing cerebral infarction or cerebral thrombus |
| 07/21/2004 | CN1158070C Immediate release tablet |
| 07/20/2004 | US6765012 For modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation |
| 07/20/2004 | US6765010 Compositions and methods for enhancing analgesic potency of tramadol and attenuating its adverse side effects |
| 07/20/2004 | US6765004 Anticoagulants, antiischemic and hypotensive agents; cardiovascular disorders, congestive heart failure, liver cirrhosis, renal vasospasm, renal failure, cerebral edema and ischemia, strokes |
| 07/20/2004 | US6764683 Stimulation of hematopoiesis in patients undergoing cytotoxic cancer chemotherapy; preventing mucositis; cytoprotection |
| 07/20/2004 | CA2254731C Inhibition of matrix metalloproteases by 2-substituted-4-(4-substitutedphenyl)-4-oxobutyric acids |
| 07/15/2004 | WO2004058790A1 Nitrogen-containing heterocycic derivatives, medicinal compositions containing the same and medicinal use thereof |
| 07/15/2004 | WO2004058745A1 Optically active dihydropyridine derivative |
| 07/15/2004 | WO2004058728A1 Novel ethylenediamine derivatives |
| 07/15/2004 | WO2004058722A1 Diarylamine and arylheteroarylamine pyrazole derivatives as modulators of 5ht2a |
| 07/15/2004 | WO2004058354A1 Compositions of cyclooxygenase-2 selective inhibitors and selective serotonin reuptake inhibitors for the treatment or prevention of a vaso-occlusive event |
| 07/15/2004 | WO2004058280A1 Method of improvement of blood circulation |
| 07/15/2004 | WO2003093422A3 Novel tissue factor targeted antibodies as anticoagulants |
| 07/15/2004 | WO2003092715A3 Proteins involved in the regulation of energy homeostasis |
| 07/15/2004 | WO2003092588A3 4-azasteroid derivatives as androgen receptor modulators |
| 07/15/2004 | WO2003087108A3 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses |
| 07/15/2004 | WO2003087040A3 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses |
| 07/15/2004 | WO2003086294A3 1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators |
| 07/15/2004 | WO2003082197A3 Immunosuppressant compounds, methods and uses related thereto |
| 07/15/2004 | US20040138739 Method of reducing thrombosis and complications after arterial angioplasty using stent coated with magnesium-based compound |
| 07/15/2004 | US20040138502 Ph-dependent nmda receptor antagonists |
| 07/15/2004 | US20040138462 Aminoalcohol derivatives |
| 07/15/2004 | US20040138454 Drugs for treating pain formed by arylation |
| 07/15/2004 | US20040138430 Novel polypeptide compose substance for promoting blood and blood vessel cell growth |
| 07/15/2004 | US20040138416 Comprises membrane protein for use in diagnosis prevention and treatment of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune, inflammatory, metabolic and viral disorders |
| 07/15/2004 | US20040138315 Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation |
| 07/15/2004 | US20040138290 Atorvastatin calcium in a pharmaceutical form composition thereof and pharmaceutical formulation comprising atorvastatin calcium |
| 07/15/2004 | US20040138287 Novel 5-phenyl-1h-indole derivatives as antagonists of interleukine-8 receptors |
| 07/15/2004 | US20040138276 Metalloproteinase inhibitors |
| 07/15/2004 | US20040138264 Tetrahydropyridly-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same |
| 07/15/2004 | US20040138262 Antiinflammatory agents; antiallergens; vision defects; anticancer agents; gastrointestinal disorders |
| 07/15/2004 | US20040138229 Platelet adenosine diphosphate receptor antagonists |
| 07/15/2004 | US20040138169 Competitive binding with enzyme involved in metabolism of homoocysteine; permeability of erythrocyte membrane; enzyme inhibitor |
| 07/15/2004 | US20040138148 Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof |
| 07/15/2004 | US20040138143 Novel thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof |
| 07/15/2004 | US20040138113 Administering heterodimeric polypeptides and optionally as mixtures with steroids, to mammals, as antiinflammatory agents; side effect reduction |
| 07/15/2004 | US20040138103 Compositions containing peptide copper complexes and metalloproteinase inhibitors and methods related thereto |
| 07/15/2004 | US20040137564 for diagnosing, treating, or preventing cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders, and viral infections;solid phase synthesis |
| 07/15/2004 | US20040137557 Remodeling and glycoconjugation of peptides |
| 07/15/2004 | US20040136908 Anti-cd19 immunotoxins |
| 07/15/2004 | DE10300049A1 Neue Verbindungen, die Faktor VIIa inhibieren Novel compounds which inhibit factor VIIa |
| 07/15/2004 | CA2512147A1 Aqueous extract of red vine leave and use thereof for improving blood circulation |
| 07/15/2004 | CA2511500A1 Novel ethylenediamine derivatives |
| 07/15/2004 | CA2509835A1 Nitrogen-containing heterocyclic derivatives, medicinal compositions containing the same and medicinal use thereof |
| 07/14/2004 | EP1437137A1 Drugs comprising combination of antithrombotic agent with pyrazolone derivative |
| 07/14/2004 | EP1437132A1 Use of nitric ester derivatives in the manufacture of a medicament for the treatment of gastrointestinal tumors |
| 07/14/2004 | EP1436624A1 A method of diagnosis and treatment and agents useful for same |
| 07/14/2004 | EP1436429A2 Targeted nucleic acid constructs and uses related thereto |
| 07/14/2004 | EP1436389A2 Thrombin-cleavable chimeric proteins |